Article
MERTK Inhibition as a Targeted Novel Cancer Therapy
12 Jul 2024
Abstract excerpt
In this issue honoring the contributions of Greg Lemke, the Earp and Graham lab teams discuss several threads in the discovery, action, signaling, and translational/clinical potential of MERTK, originally called c-mer, a member of the TYRO3, AXL, and MERTK (TAM) family of receptor tyrosine kinases. The 30-year history of the TAM RTK family began slowly as all three members were orphan RTKs without known ligands...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
